Ketamine for treatment-resistant depression: recent developments and clinical applications April 6, 2016
The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study January 29, 2016
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression January 11, 2016
[Interview] Phil Wolfson deems MDMA, ketamine and psychedelics “not terribly different” November 2, 2015
Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression October 29, 2015
